CCRM, and its partners, will deliver on the promise to make Canada a global leader in Regenerative Medicine (RM) asset development and commercialization.
CECR creates centres to advance research and facilitate commercialization of technologies, products and services in four key areas: environment, natural resources and energy; health and life sciences; and information communications technologies. The CECR program supports the operating expenses of a centre, and the commercialization of such research. The CECR program helps bridge the gap between innovation and commercialization, allowing new products and technologies to go to market more easily. CCRM is a CECR Centre.
The Networks of Centres of Excellence (NCE) fosters multi-disciplinary, multi-sectoral partnerships between academia, industry, government and not-for-profit organizations. It supports academic research, the commercialization of products and ideas, and the development of significant Canadian business advantages. The partnerships that this initiative cultivates result in ideas that are transformed into economic and social benefits for all Canadians.
- MaRS Innovation (MI)
MI takes the most promising breakthroughs from 17 of Toronto’s top universities and research institutes, and commercializes them. They bring together the scientists and inventors from these member institutions with investors who are looking for high-potential opportunities, especially in the biosciences and technology. MI is a Centre of Excellence for Commercialization and Research (CECR) and is located in MaRS Discovery District.
- MaRS Discovery District (MaRS DD)
MaRS DD is an innovation centre connecting the worlds of science, business and capital with the goal of dramatically improving commercial outcomes for entrepreneurs. Located in the heart of Toronto and networked across Ontario, the MaRS Centre is the gateway to Canada’s largest concentration of scientific research, anchored by major teaching hospitals, universities, and research institutes, adjacent to leading financial institutions and surround by a creative urban community. MaRS is a member of the Ontario Network of Excellence.
- Ontario Stem Cell Initiative (OSCI)
OSCI is a virtual network of more than 100 stem cell research programs in Ontario whose mission is to enhance international excellence in stem cell science, promote international partnerships with Ontario researchers, and facilitate commercialization and translation of stem cell research into improved health. OSCI’s slogan, "Innovate & Challenge Fate," encompasses the work of its scientists who are challenging cell and disease fate through their innovative work. OSCI is located at the University of Toronto and is networked across Ontario. OSCI receives funding from the Canadian Foundation for Innovation, the Ministry of Research & Innovation and the Ontario Research Fund.
- Stem Cell Network (SCN)
In pursuit of Canadian excellence and global leadership in applied stem cell research, the SCN supports cutting-edge projects that translate research discoveries into new and better treatments for millions of patients in Canada and around the world. More than 100 scientists, clinicians, engineers, and social scientists with international reputations work closely together within the Stem Cell Network to bring rigor and innovation to Canadian stem cell research. SCN is a Network of Centres of Excellence (NCE) and is located in Ottawa.
The McEwen Centre’s vision is to be a world-renowned centre for stem cell biology and regenerative medicine. To achieve this goal, the team of McEwen Investigators is working together to accelerate the development of more effective treatments for conditions such as heart disease, diabetes, respiratory disease and spinal cord injury. The McEwen Centre is based at the MaRS Centre/Toronto Medical Discovery Tower. The McEwen Centre was established at the University Health Network in 2003 with a generous donation from Rob and Cheryl McEwen, which they matched in 2006 with a second donation.
CGP is at the crossroads of the legal, medical and public policy fields. The CGP promotes prospective structuring and guidance for both research in genomic health sciences and its applications. Currently CGP's research covers five areas of genomics and policy: procreation and reproductive genetics, pediatric health, privacy, public health, and personalized medicine. These domains are approached using three guiding foundations: internationalization, policy development and knowledge transfer. CGP allows CCRM to be at the forefront of responsible governance.